Liofora

Drospirenone/Ethinylestradiol, the active ingredients in Liofora, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy by inhibiting ovulation and altering cervical mucus in women of reproductive age, and providing reliable birth control through hormonal regulation.

GNH USA supplies Liofora as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers, offering consistent batch release, traceability, and regulatory support throughout the supply chain.

Liofora, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy. - Prevention of pregnancy: Provides reliable contraception for women of childbearing potential. - Treatment of moderate acne: Helps reduce acne lesions while offering contraceptive protection. - Management of menstrual disorders: Improves cycle regularity and reduces heavy or irregular bleeding.

Liofora may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort of the breasts. - Weight gain: slight increase in body weight, often due to fluid retention.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Hypertension: significant increase in blood pressure. - Liver dysfunction: abnormal liver enzyme levels or jaundice.

Before prescribing Liofora, healthcare professionals should consider several precautionary measures to ensure safe use. - Smoking status: Avoid use in women over 35 who smoke due to increased cardiovascular risk. - Cardiovascular history: Assess for hypertension, thromboembolic disorders, or coronary artery disease. - Liver function: Evaluate hepatic impairment as metabolism may be affected. - Migraine with aura: Contraindicated in patients experiencing migraine with visual disturbances. - Concomitant medications: Review use of enzyme‑inducing drugs that may reduce efficacy. - Store at ambient temperature: Keep tablets below 25 °C in the original packaging, protected from moisture and light.

Liofora can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Strong CYP3A4 inducers: Antiepileptics such as carbamazepine or rifampicin can markedly reduce hormone levels. - Anticoagulants: Combined oral contraceptives may enhance the effect of warfarin, requiring close monitoring. - Certain antibiotics: Griseofulvin may decrease contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antifungals: Ketoconazole can increase hormone concentrations, raising side‑effect risk. - St. John’s wort: May modestly lower contraceptive effectiveness. - Antidepressants: Selective serotonin reuptake inhibitors may increase the risk of mood changes.